|
RBM14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.657140E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.090370E-01 |
| Normal-vs-Stage2 |
6.500800E-03 |
| Normal-vs-Stage3 |
6.31030000000088E-05 |
| Normal-vs-Stage4 |
3.75860000000339E-05 |
| Stage1-vs-Stage2 |
5.465700E-02 |
| Stage1-vs-Stage3 |
4.442700E-04 |
| Stage1-vs-Stage4 |
5.414000E-04 |
| Stage2-vs-Stage3 |
5.416400E-01 |
| Stage2-vs-Stage4 |
3.992400E-01 |
| Stage3-vs-Stage4 |
7.587000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.231900E-04 |
| Normal-vs-AfricanAmerican |
5.752400E-01 |
| Normal-vs-Asian |
2.973600E-01 |
| Caucasian-vs-AfricanAmerican |
1.341970E-02 |
| Caucasian-vs-Asian |
1.561950E-03 |
| AfricanAmerican-vs-Asian |
5.122200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.82100000000385E-05 |
| Normal-vs-Female |
2.867400E-01 |
| Male-vs-Female |
1.66117000000021E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.352200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.730270E-02 |
| Normal-vs-Age(61-80Yrs) |
7.229900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.161730E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.073800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.363000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.757200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.869990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.001000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.321600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.632400E-02 |
| Normal-vs-Grade 2 |
1.087620E-01 |
| Normal-vs-Grade 3 |
1.95839999999059E-05 |
| Normal-vs-Grade 4 |
4.27539999999782E-05 |
| Grade 1-vs-Grade 2 |
3.156200E-03 |
| Grade 1-vs-Grade 3 |
3.16239999997858E-06 |
| Grade 1-vs-Grade 4 |
1.53729999999852E-05 |
| Grade 2-vs-Grade 3 |
3.401100E-04 |
| Grade 2-vs-Grade 4 |
7.825700E-04 |
| Grade 3-vs-Grade 4 |
3.594200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.714810E-01 |
| Normal-vs-ccB subtype |
1.25829999997329E-06 |
| ccA subtype-vs-ccB subtype |
1.01669999996723E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.940800E-03 |
| Normal-vs-N1 |
6.157500E-03 |
| N0-vs-N1 |
9.934200E-02 |
|
|
